Is Global X Genomics & Biotechnology ETF halal to invest in?

As of September 2026, Global X Genomics & Biotechnology ETF GNOM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Global X Genomics & Biotechnology ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Global X Genomics & Biotechnology ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Global X Genomics & Biotechnology ETF updated?

The Shariah compliance status of Global X Genomics & Biotechnology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Global X Genomics & Biotechnology ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Global X Genomics & Biotechnology ETF?

You can check the latest Shariah compliance status of Global X Genomics & Biotechnology ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Global X Genomics & Biotechnology ETF GNOM

GNOM Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Global X Genomics & Biotechnology ETF is classified as not halal.

NOT HALAL

Is Global X Genomics & Biotechnology ETF Halal?

Shariah Compliance Analysis of GNOM ETF

US Equity Theme

No. As of September 2026, Global X Genomics & Biotechnology ETF (GNOM) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Global X Genomics & Biotechnology ETF does not pass Musaffa's business and financial screening criteria.

GNOM was created on 2019-04-05 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 53.96m in AUM and 51 holdings. GNOM tracks an index of global biotech equities, selected and weighted by market cap.

Global X Genomics & Biotechnology ETF (GNOM) Chart

Key Statistics of Global X Genomics & Biotechnology ETF (GNOM)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
99.98%

FAQ's for Global X Genomics & Biotechnology ETF (GNOM)

As of September 2026, Global X Genomics & Biotechnology ETF GNOM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Global X Genomics & Biotechnology ETF using these criteria to determine its compliance status.
The Shariah compliance status of Global X Genomics & Biotechnology ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Global X Genomics & Biotechnology ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.